Pfäffikon SZ/Leverkusen/Hamburg – The CO2 investment platform Callirius has supported the chemical and pharmaceutical group Bayer in improving its own climate footprint. In their first major transaction, Bayer invested in the biochar of the Hamburg-based company Novocarbo, thereby acquiring voluntary CO2 certificates.
Canton Schwyz-based fintech Callirius has completed its first major transaction. Through its digital marketplace, the platform for trading CO2 certificates brought Leverkusen-based chemical and pharmaceutical giant Bayer together with Novocarbo. The Hamburg-based company produces plant carbon (Biochar) from biomass and stores carbon in this way. Bayer invested in Novocarbo through Callirius. In return, the Group received CO2 certificates to offset its own emissions.
“Biochar is a particularly promising carbon-removal technology for us because, in addition to actively removing CO2 from the atmosphere, it also brings positive effects as a soil conditioner for agriculture,” explains Dr. Klaus Kunz, responsible for environmental, social and governance (ESG) at Bayer, in a Callirius media release. “We are pleased to be actively promoting sustainable and forward-thinking solutions for the agricultural sector while continuing to move forward on the path to Net Zero.”
Callirius was founded in Pfäffikon at the end of 2022 by former top managers from the German financial sector. “The voluntary carbon market is dysfunctional,” the company explains. “Callirius is here to make it effective.” The platform aims to bring companies together with forest owners, farmers and climate project developers.
The goal: to provide funding for effective, nature-based solutions to actively decarbonize the atmosphere. “This transaction between Bayer AG and Novocarbo could not be a better example of how important our platform and service offering are to joint climate change efforts,” said Callirius co-founder and CEO Ebrahim Attarzadeh. ce/mm